Literature DB >> 32118289

The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: a case series of seven patients.

K Harada1, R Irisawa1, T Ito1, M Uchiyama1, R Tsuboi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32118289     DOI： 10.1111/bjd.18976

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

Review 2.  Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point.

Authors:  Bo Xie; Jiayi Sun; Xiuzu Song
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-19       Impact factor: 10.817

Review 3.  [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Authors:  Stephan Traidl; Annice Heratizadeh
Journal:  Dermatologie (Heidelb)       Date:  2022-06-01

4.  Mild hypertrichosis in both upper arms around dupilumab injection sites.

Authors:  Hitomi Sugino; Motonobu Nakamura
Journal:  Eur J Dermatol       Date:  2021-06-01       Impact factor: 3.328

5.  Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.

Authors:  Maurizio Romagnuolo; Mauro Barbareschi; Simona Tavecchio; Luisa Angileri; Silvia Mariel Ferrucci
Journal:  Skin Appendage Disord       Date:  2021-07-27

6. 

Authors:  F Cambazard
Journal:  Ann Dermatol Venereol       Date:  2020-12       Impact factor: 0.777

Review 7.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.